Like every diabetic I know, I don’t like to think about complications. Heart disease, nephropathy, neuropathy, retinopathy. Foot ulcers.…
A two-juice-box night, in fact. This is what I saw on my nightstand as I was puttering around my room getting dressed this morning.
While I do recall…
Studies have shown that excess insulin circulating in the bloodstream is a major independent risk factor for cardiovascular disease. However, a new study from Joslin Diabetes Center finds that this condition, called hyperinsulinemia, itself does not cause hardening of the arteries, also known as atherosclerosis...
What are the statistical chances of getting type 1 diabetes along with your spouse in your third decade of living?
How’s that for a depressing subject line? It’s the topic of a mini-article I just had published in this weekend’s issue of Parade…
Getting an insulin pump has changed my life for the better. It’s true that it isn’t always convenient, and I occasionally get some remarks or questions,…
At the university where I work, every spring there is a 12-week community fitness program, called Getfit MIT, in which teams of 5 to 8 people compete…
Men with type 2 diabetes who are treated with insulin are at higher risk risk for major cardiovascular events (e.g., death, heart attack, stroke) according to a new study conducted by researchers at Brigham and Women's Hospital (BWH). The researchers found that men with type 2 diabetes treated...
American Diabetes Association Alert Day® is a one-day "wake-up call” asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing type 2 diabetes. Held on the fourth Tuesday of every March, the next Alert Day will be held on March 27, 2012.
For every Diabetes Risk Test taken, Boar’s Head® - manufacturer of premium delicatessen products - will donate $5 to the American Diabetes Association starting March 27 through April 27, 2012, up to $50,000.
The European Commission has granted marketing authorization to Byetta (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents...